ARTICLE
21 June 2016

FDA Publishes Final Rule Against Intentional Adulteration

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
FDA has published its last major regulation implementing the Food Safety and Modernization Act ("FSMA"): a final rule on mitigation strategies to protect food against intentional adulteration.
United States Food, Drugs, Healthcare, Life Sciences

FDA has published its last major regulation implementing the Food Safety and Modernization Act ("FSMA"): a final rule on mitigation strategies to protect food against intentional adulteration. This rule is aimed at preventing intentional adulteration from acts intended to cause wide-scale harm to public health, including acts of terrorism targeting the food supply. Under the new rule, both domestic and foreign food facilities, for the first time, are required to complete and maintain a risk-reducing written food defense plan that assesses potential vulnerabilities and mitigation strategies, establish food defense monitoring procedures and corrective actions, verify the system is working, and ensure personnel assigned to the vulnerable areas receive appropriate training and maintain certain records. The final rule requires companies to perform a vulnerability assessment based on the evaluation of: (i) the severity and scale of the potential public health impact; (ii) the degree of physical access to the product; and (iii) the ability to successfully contaminate the product, which represents a change as compared to the proposed rule. In addition, the final rule extends the list of exempt facilities. It also give those companies subject to the rule more time to comply. For instance, most companies have three years to comply with the new rule, small companies (500 employees or less) have four years, and very small companies (sales of less than $10 million per year during three consecutive years) must comply in five.

FDA has published a summary of the final rule covering key requirements and a diagram intended to assist companies in understanding whether the new rule applies to them. Additionally, FDA will host a webinar on the topic on June 21, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More